Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2011 2
2012 4
2013 3
2014 2
2015 10
2016 7
2017 8
2018 8
2019 4
2020 6
2021 2
2022 1
2023 0
Text availability
Article attribute
Article type
Publication date

Search Results

48 results
Results by year
Filters applied: . Clear all
Page 1
Pitfalls and Limitations in Simultaneous PET/MRI.
Delso G, ter Voert E, de Galiza Barbosa F, Veit-Haibach P. Delso G, et al. Among authors: ter voert e. Semin Nucl Med. 2015 Nov;45(6):552-9. doi: 10.1053/j.semnuclmed.2015.04.002. Semin Nucl Med. 2015. PMID: 26522396 Review.
How does PET/MR work? Basic physics for physicians.
Delso G, Ter Voert E, Veit-Haibach P. Delso G, et al. Among authors: ter voert e. Abdom Imaging. 2015 Aug;40(6):1352-7. doi: 10.1007/s00261-015-0437-5. Abdom Imaging. 2015. PMID: 25906344 Free article. Review.
Tumour response prediction by diffusion-weighted MR imaging: ready for clinical use?
Heijmen L, Verstappen MC, Ter Voert EE, Punt CJ, Oyen WJ, de Geus-Oei LF, Hermans JJ, Heerschap A, van Laarhoven HW. Heijmen L, et al. Among authors: ter voert ee. Crit Rev Oncol Hematol. 2012 Aug;83(2):194-207. doi: 10.1016/j.critrevonc.2011.12.008. Epub 2012 Jan 23. Crit Rev Oncol Hematol. 2012. PMID: 22269446 Review.
PET/MR Outperforms PET/CT in Suspected Occult Tumors.
Sekine T, Barbosa FG, Sah BR, Mader CE, Delso G, Burger IA, Stolzmann P, Ter Voert EE, von Schulthess GK, Veit-Haibach P, Huellner MW. Sekine T, et al. Among authors: ter voert ee. Clin Nucl Med. 2017 Feb;42(2):e88-e95. doi: 10.1097/RLU.0000000000001461. Clin Nucl Med. 2017. PMID: 27922861 Free article.
Feasibility of 18F-FDG Dose Reductions in Breast Cancer PET/MRI.
Sah BR, Ghafoor S, Burger IA, Ter Voert EEGW, Sekine T, Delso G, Huellner M, Dedes KJ, Boss A, Veit-Haibach P. Sah BR, et al. Among authors: ter voert eegw. J Nucl Med. 2018 Dec;59(12):1817-1822. doi: 10.2967/jnumed.118.209007. Epub 2018 Jun 7. J Nucl Med. 2018. PMID: 29880506 Free article.
48 results